Heparan sulfate proteoglycan-involving immunomodulation by cathelicidin antimicrobial peptides LL-37 and PR-39.
Division of General Internal Medicine, Department of Internal Medicine, Medical University of Innsbruck, Austria.
Nicole C
NC
Kaneider
Angela
A
Djanani
Christian J
CJ
Wiedermann
D000818:Animals; D023181:Antimicrobial Cationic Peptides / Q000276:immunology*; D019812:Heparan Sulfate Proteoglycans / Q000276:immunology*; D006801:Humans; D007113:Immunity, Innate / Q000276:immunology*; D007155:Immunologic Factors / Q000276:immunology*; D007962:Leukocytes / Q000276:immunology; D018448:Models, Immunological; D054804:Cathelicidins
D023181:Antimicrobial Cationic Peptides; D019812:Heparan Sulfate Proteoglycans; D007155:Immunologic Factors; C072212:PR 39; D054804:Cathelicidins